Effect of pimecrolimus on oral lichen planus: A systematic review

Chinese Journal of Evidence-Based Medicine

Volumn 8, Issue 4, 2008, Pages 261-266

  Gong, Zhong Cheng ^a   Lin, Zhao Quan ^a   Adili, Moming ^a   Wang, Ling ^a   Xiong, Hui ^b   Liao, Feng ^b   Long, Xing ^b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Oral lichen planus; Pimecrolimus; Randomized controlled trial; Systematic review

Indexed keywords

PIMECROLIMUS; PLACEBO; TRIAMCINOLONE ACETONIDE;

BIOMEDICINE; BURNING SENSATION; CLINICAL EVALUATION; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; COMPUTER PROGRAM; CONFIDENCE INTERVAL; DATA ANALYSIS; DATA BASE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EMBASE; HEALTH; HEALTH STATUS; HUMAN; LICHEN PLANUS; MEDLINE; MOUTH CAVITY; MOUTH PAIN; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE;

EID: 43049111094     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Axell T. Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people. Community Dent Oral Epidemiol, 1987, 15: 46-51.
2. Altman J, Perry HO. The variations and course of lichen planus. Arch Dermatol, 1961, 84: 179-191.
3. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol, 2002, 46: 207-214.
4. Lodi G, Scully C, Carrozzo M, et al. Current controversies in oral lichen planus: report of an international consensus meeting, part 2; clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2005, 100: 164-178.
5. Stuetz A, Grassberger M, Meingassner JG. Pimecrolimus (Elidel, SDZ ASM981) -preclinical pharmacologic profile and skin selectivity. Semin Cutan Med Surg, 2001, 20(4): 233.
6. Gorouhi F, Solhpour A, Beitollahi JM, et al. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus. J Am Acad Dermatol, 2007, 57(5): 806-813.
7. Passeron T, Lacour JP, Fontas E, et al. Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. Arch Dermatol, 2007, 143(4): 472-476.
8. Scheer M, Kawari-Mahmoodi N, Neugebauer J, et al. Pimecrolimus (Elidel) for therapy of lichen ruber mucosae. Mund Kiefer Gesichtschir, 2006, 10(6): 403-407.
9. Cedro M, Chaudhry S, Porter S. OC10 Topical pimecrolimus for the treatment of erosive oral lichen planus. Oral Dis, 2006, 12(s1): 11.
10. Swift JC, Rees TD, Plemons JM. The effectiveness of 1% pimecrolimus cream in the treatment of oral erosive lichen planus. J Periodontal, 2005, 76(4): 627-635.
11. Thongprasom K, Luangjarmekorn L, Sererat T, et al. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med, 1992, 21: 456-458.
12. Scott J, Huskisson EC. Graphic representation of pain. Pain, 1976, 2: 175-184.
13. Slade GD. Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol, 1997, 25: 284-290.
14. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.4 [updated March 2005]. In: The Cochrane Library, Issue 2, 2005.
15. Moher D, Pham B, Jones A, et al. Does quality of reports of randomized trials affect estimates of intervention eficacy reported in Meta-analyses. Lancet, 1998, 352(9128): 609-613.
16. Anon. News: Cream for atopic enzema launched. Pharm J, 2002, 269(7220): 560-563.
17. Meingassner JG, Kowalsky E, Schwendinger H, et al. Pimecrolimus does not affect Langerhans cells in murine epidermis. Br J Dermatol, 2003, 149: 853-857.
18. Billich A, Aschauer H, Aszodi A, et al. Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm, 2004, 269: 29-35.
19. Gupta AK, Chow M. Pimecrolimus: a review. J Eur Acad Dermatol Venereol, 2003, 17: 493-503.
20. Dissemond J, Schroter S, Franckson T, et al. Pimecrolimus in an adhesive ointment as a new treatment option for oral lichen planus. Br J Dermatol, 2004, 150: 782-784.
21. Esquivel-Pedraza L, Fernandez-Cuevas L, Ortiz-Pedroza G, et al. Treatment of oral lichen planus with topical pimecrolimus 1% cream. Br J Dermatol, 2004, 150: 771-773.
22. Allen BR, Lakhanpaul M, Morris A, et al. Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients. Arch Dis Child, 2003, 88: 969-973.
23. Rappersberger K, Komar M, Ebelin ME, et al. Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated. J Invest Dermatol, 2002, 119: 876-887.
24. Lo Muzio L, della Valle A, Mignogna MD, et al. The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients. J Oral Pathol Med, 2001, 30: 611-617.
25. Carbone M, Goss E, Carrozzo M, et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med, 2003, 32: 323-329.
26. Berger TG, Duvic M, Van Voorhees AS, et al. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association task force. J Am Acad Dermatol, 2006, 54: 818-823.
27. Spergel JM, Leung DY. Safety of topical calcineurin inhibitors in atopic dermatitis: evaluation of the evidence. Curr Allergy Asthma Rep, 2006, 6: 270-274.